Back to KRYS

Hennion & Walsh Asset Management, Inc. → KRYS

Hennion & Walsh Asset Management, Inc. KRYS Position History

Krystal Biotech, Inc. • Healthcare

Quarters held
2
Latest value
$496K
Q3 2026
Peak value
$496K
First seen
Q2 2026

Dollar value over time

Show data table
PeriodPosition value
Q2 2026$337K
Q3 2026$496K

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$496K1.5K——
Q2 2026$337K906——

Other funds holding KRYS

Other Hennion & Walsh Asset Management, Inc. positions

ETHA

ISHARES TR

$150.4M
ETHA

ISHARES TR

$143.4M
ETHA

ISHARES TR

$117.3M
ETHA

ISHARES TR

$115.9M
ETHA

ISHARES TR

$110.8M
GS-PD

GOLDMAN SACHS ETF TR

$70.5M
GS-PD

GOLDMAN SACHS ETF TR

$70.4M
GS-PD

GOLDMAN SACHS ETF TR

$68.2M